U.S.-based drugmaker Pfizer is seeking to make a booster shot of its COVID-19 vaccine available to all adult Americans 18 years of age and older
More
The United States will soon reopen its air borders for foreign visitors who are fully vaccinated with an approved vaccine or those who can present a negative COVID-19 test within 24 hours of travel, the White House announced Monday.
More
Public frustration over Japan's slow vaccine roll-out is intensifying after it emerged that the European Union approved the export of more than 50 million Covid-19 shots to the country this year, the most among nations the bloc is shipping to.
More
Scammers are using a new trick to steal your money and personal information: a bogus COVID vaccine survey.
More
Even as the pace of vaccination against covid-19 has steadily accelerated — hitting an average of 1.3 million doses a day in the last days of January — the frustration felt by many of those unable to secure an appointment hasn’t waned.
More
To speed up access to COVID-19 vaccinations in the developing world, on the eve of the new year, the UN health agency approved Pfizer and BioNTech’s vaccines for emergency use.
More
Myovant and Pfizer to jointly develop and commercialize ORGOVYX™ (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and Canada
More
Addressing the financing gap to provide COVID-19 vaccines for everyone, everywhere, is an urgent priority, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Friday, in an appeal for stepped-up funding to support poorer countries.
More
EMA Executive Director Emer Cooke will update MEPs on the latest developments concerning the authorisation of vaccines against COVID-19, on Thursday at 14.00.
More